| Cover | Nov. 01, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 01, 2024 |
| Entity File Number | 001-37937 |
| Entity Registrant Name | Xenetic Biosciences, Inc. |
| Entity Central Index Key | 0001534525 |
| Entity Tax Identification Number | 45-2952962 |
| Entity Incorporation, State or Country Code | NV |
| Entity Address, Address Line One | 945 Concord Street |
| Entity Address, City or Town | Framingham |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 01701 |
| City Area Code | (781) |
| Local Phone Number | 778-7720 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value per share |
| Trading Symbol | XBIO |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
